Harmonica Exercises for Patients Undergoing Cardiac Rehabilitation.
HARMONYCR
The Effect of Harmonica Exercises on Cardiorespiratory Exercise Capacity Parameters, Quality of Life and Symptoms of Depression in Patients Undergoing Cardiac Rehabilitation.
1 other identifier
interventional
80
1 country
1
Brief Summary
The study aims to assess the effects of exercises using the harmonica on the exercise capacity, the level of depressive symptoms and disease related quality of life in patients suffering from heart disease attending cardiac rehabilitation program. The main questions it aims to answer are: Does harmonica exercise improve exercise capacity in patints with herat disease? Does harmonica exercise affect depression levels and health-related quality of life in patients with heart disease? Researchers will explore the effect of harmonica exercise on exercise capacity and selected psychological aspects of patients participating in cardiac rehabilitation program Participants will: Complete a cardiac rehabilitation program with assessment of exercise capacity at the beginning and end of the program Perform breathing exercises only or breathing exercises and harmonica exercises Keep a diary of their exercises
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable coronary-artery-disease
Started May 2024
Shorter than P25 for not_applicable coronary-artery-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 16, 2024
CompletedFirst Submitted
Initial submission to the registry
September 29, 2024
CompletedFirst Posted
Study publicly available on registry
October 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2025
CompletedOctober 17, 2024
September 1, 2024
1 year
September 29, 2024
October 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
exercise capacity
Exercise capacity assessed by cardiopulmonary exercise testing measured by peak oxygen consumption.
from enrollment to the end of cardiac rehabilitataion at 5 weeks
health related quality of life
Health related quality of life measured by the EuroQOL five dimensions questionnaire.This is a self-reported description of the subject's current health in 5 dimensions i.e., mobility, self-care, usual activities, pain/discomfort and anxiety/depression
from enrollment to the end of cardiac rehabilitataion program at 5 weeks
symptoms of depression
Syptoms of depressin measured by Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 is a multipurpose instrument for screening, diagnosing, monitoring and measuring the severity of depression. Total scores of 5, 10, 15, and 20 represent cutpoints for mild, moderate, moderately severe and severe depression, respectively
from enrollment to the end of cardiac rehabilitataion program at 5 weeks
Study Arms (2)
study arm
EXPERIMENTALpatients randomized to the study arm will receive a breathing exercise program with standard diatonic mouth harmonica
control arm
NO INTERVENTIONpatients randomized to the control arm will follow standard cardiac rehabilitation program with breathing exercises only
Interventions
In addition to regular breathing exercises, participants will perform harmonica exercises
Eligibility Criteria
You may qualify if:
- patients participating in cardiac rehabilitation program
You may not qualify if:
- Decompensated heart failure, with symptoms in NYHA class II-IV within 3 weeks before admission to the Cardiac Rehabilitation Department
- Poorly controlled hypertension (BP in office measurement \>160/100 mmHg)
- Severe symptomatic heart disease (including valvular);
- Other severe comorbidities, including those significantly limiting physical performance: chronic kidney disease with GFR \<30 ml/min/1.73m2 (according to the CKD-EPI formula), severe form of bronchial asthma/chronic obstructive pulmonary disease (stage C/D ), hypertrophic cardiomyopathy, significant cardiac arrhythmias (persistent/permanent atrial fibrillation, sustained supraventricular/ventricular tachycardia, multiple supraventricular/ventricular extrasystole \> 10,000/day), pulmonary embolism in the last 3 months, acute coronary syndrome in the last 7 days, peripheral arterial disease with claudication distance \<200 m, generalized active neoplastic process;
- mental illness/dementia syndrome that prevents full cooperation with the examined person;
- diseases of the musculoskeletal system that make it impossible to perform an exercise test;
- contraindications to performing an exercise test;
- contact allergy to the materials from which the body/cover of the harmonica is made, revealed during exercises
- lack of consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiac Rehabilitation Department, Military Institute of Medicine National research Institute
Warsaw, 04-411, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Katarzyna Piotrowicz, MD, PhD, MS
Military Institute of Medicine
- PRINCIPAL INVESTIGATOR
Anna Mierzyńska, PhD, MS
Military Institute of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Cardiac Rehabilitation Department
Study Record Dates
First Submitted
September 29, 2024
First Posted
October 17, 2024
Study Start
May 16, 2024
Primary Completion
May 31, 2025
Study Completion
May 31, 2025
Last Updated
October 17, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share